Woerle Hans-Juergen

Seres Therapeutics, Inc. · Director

Woerle Hans-Juergen is listed in filings as Director at Seres Therapeutics, Inc.. This profile follows SEC Form 4 activity through Feb 6, 2025, including 1 public disclosure. Recent filings connect the profile to Seres Therapeutics, Inc. (MCRB). The current snapshot covers public activity from Feb 6, 2025. Reported amounts are shown as $96.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

History Trades

CompanyValueActionPriceCurrent Price
Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available.